A global hub of interdisciplinary innovation for the elimination of poverty-driven corneal blindness in poor communities worldwide.
A $2m program of collaborative research with Harvard Medical School in Boston to achieve new breakthroughs in corneal disease.
Leading the scientific development a proprietary biosynthetic to reduce reliance on expensive surgery to cure corneal blindness.
Funding the purchase of the world’s first clinically-approved 3D-printed bionic arms for young people in the UK with limb difference.
Supporting targeted projects within underserved communities where direct interventions can have a sustained and positive impact.
Dr. Sanduk Ruit and Mr Tej Kohli are united in their mission to create a lasting legacy of social and economic change in poor and underserved communities by screening 1,000,000 people and curing up to 500,000 of needless cataract blindness.
“I rebuilt myself into a big success, and I’m determined to use that success to help rebuild others too. I am extremely proud of the impact that I have been able to make. Of course no matter what you do there will always be people who want to bring you down. But they only want to see you down because it makes them feel better about themselves. Don’t give them that satisfaction. Keep building yourself. Keep giving back. And keep helping others.”
Mr. Tej Kohli
& Ruit Foundation
The Tej Kohli & Ruit Foundation unites Tej Kohli‘s aptitude for funding large-scale grassroots programs of intervention with ‘God of Sight‘ Dr. Sanduk Ruit‘s expertise in curing cataracts at volume. The Tej Kohli Foundation is seeking to screen 2,000,000 cataract patients and to cure at least 300,000 patients of blindness by 2026 through a series of microsurgical outreach camps in Asia and Africa.
For nearly two decades, the not-for-profit Tej Kohli Foundation has been making long-term grassroots interventions to create projects in poor and underprivileged communities around the world. The goal is to address a myriad of issues that arise from inequality and poverty.
The Tej Kohli Cornea Institute is an eminent institution for R&D, preventative medicine, and corneal transplants. Between January 2016 and November 2019 it welcomed 223, 404 outpatients and carried out 43,255 surgical procedures, largely for free. The Institute also delivers prevention, treatment, and cures for corneal blindness within some of the world’s poorest communities in remote and rural areas.
Supported by an advisory board that includes the most eminent ophthalmologists from around the world, the Tej Kohli Research Centre is engaged in the pursuit of an accessible, affordable and scalable solution for eliminating corneal blindness that does not rely on surgery or donated cornea, through the development of proprietary synthetic biotech that could be relevant to one-third of those waiting for corneal transplants worldwide.
The Tej Kohli Cornea Program at Mass. Eye & Ear, a teaching hospital of Harvard Medical School, is a $2m program to accelerate innovative and collaborative research to achieve unprecedented breakthroughs in corneal disease. The Tej Kohli Cornea Program includes cutting-edge molecular technology for the rapid diagnosis of corneal infection, and also GelCORE, an adhesive biomaterial for replacing corneal tissue.
The Tej Kohli Future Bionics program highlights how technology can substantially improve the lives and confidence of younger people living with disabilities. The program epitomises the Tej Kohli Foundation’s focus on helping young people who are living with disabilities by making a direct and meaningful intervention into their lives using technology. The program funds the purchase and fitting of the bionic multi-grip myoelectric controlled prosthetic ‘Hero Arm’ for young people in the United Kingdom who are living with limb differences.
The Tej Kohli Foundation supports projects in underserved communities where direct interventions can have a sustained and positive impact on individual lives. ‘Impact Initiatives’ include financial support for disabled children in Costa Rica, feeding over 1,000 schoolchildren in poor communities every day at after-school clubs, and producing a ‘social impact entertainment’ film to highlight the neglect of young people in India who are living with XP, a rare genetic disease.